Drug-related problems in patients with erectile dysfunctions and multiple comorbidities

References

• NIH Consensus Conference. Impotence. NIH Consensus Development Panel on ImpotenceJAMA1993270183908510302
   PubMed Web of Science ®Google Scholar
• LewisRWFugl-MeyerKSCoronaGDefinitions/epidemiology/risk factors for sexual dysfunctionJ Sex Med201074 Pt 21598160720388160
   PubMed Web of Science ®Google Scholar
• AytaIAMcKinlayJBKraneRJThe likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequencesBJU Int1999841505610444124
   PubMed Web of Science ®Google Scholar
• RosenRCFisherWAEardleyINiederbergerCNadelASandMMen’s Attitudes to Life Events and Sexuality (MALES) StudyThe multinational Men’s Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general populationCurr Med Res Opin200420560761715171225
   PubMed Web of Science ®Google Scholar
• ChaoJKHwangTISContemporary management of erectile dysfunctionUrol Sci20132423540
   Google Scholar
• ChiurliaED’AmicoRRattiCGranataARRomagnoliRModenaMGSubclinical coronary artery atherosclerosis in patients with erectile dysfunctionJ Am Coll Cardiol20054681503150616226175
   PubMed Web of Science ®Google Scholar
• WespesEErectile dysfunction: the medical treatmentEur Urol Suppl20131221317
   Web of Science ®Google Scholar
• HatzimouratidisKAmarEEardleyIEuropean Association of UrologyGuidelines on male sexual dysfunction: erectile dysfunction and premature ejaculationEur Urol201057580481420189712
   PubMed Web of Science ®Google Scholar
• WespesEEardleyIGiulianoFGuidelines on male sexual dysfunction: erectile dysfunction and premature ejaculationEuropean Association of Urology2014 Available from: https://uroweb.org/wp-content/uploads/14-Male-Sexual-Dysfunction_LR.pdfAccessed April 12, 2015
   Google Scholar
• Pharmaceutical Care Network Europe FoundationPCNE Classification for Drug Related Problems Version 5.012010
   Google Scholar
• GareriPCastagnaAFrancomanoDCerminaraGDe FazioPErectile dysfunction in the elderly: an old widespread issue with novel treatment perspectivesInt J Endocrinol20142014115
   Web of Science ®Google Scholar
• WootenJGalavisJPolypharmacy. Keeping the elderly safeRN20056884450
   PubMedGoogle Scholar
• Ab RahmanAAAl-SadatNYun LowWPrevalence of erectile dysfunction in primary care setting, MalaysiaJ Mens Health20118Suppl 1S50S53
   PubMed Web of Science ®Google Scholar
• ValderasJMStarfieldBSibbaldBSalisburyCRolandMDefining comorbidity: implications for understanding health and health servicesAnn Fam Med200974354363
   Web of Science ®Google Scholar
• World Health Organization (WHO)Proposed working definition of an older person in Africa for the MDS Project2013 Available from: http://www.who.int/healthinfo/survey/ageingdefnolder/en/Accessed May 20, 2015
   Google Scholar
• ZainudinSDaudZMohamadMTong BoonATWan MohamedWMIA summary of the Malaysian clinical practice guidelines on management of obesityJ ASEAN Fed Endocr Soc2011262
   Google Scholar
• ViktilKKBlixHSMogerTAReikvamAPolypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problemsBr J Clin Pharmacol200763218719516939529
   PubMed Web of Science ®Google Scholar
• VenesDTaber’s Cyclopedic Medical DictionaryPhiladelphia USAF.A. Davis Company2013
   Google Scholar
• LacyCFArmstrongLLGoldmanMPLanceLLDrug Information Handbook20th edHudson, OHLexi-Comp Inc.2011
   Google Scholar
• MIMS Malaysia128th edUBM Medica Pacific Ltd2012
   Google Scholar
• MedscapeAlprostadil intracavernous/urethral (Rx) Available from: http://reference.medscape.com/drug/caverject-edex-alprostadil-342846Accessed April 27, 2015
   Google Scholar
• KlonerRANew drugs and technologies: cardiovascular effects of the 3 phosphodiesterase-5 inhibitors approved for the treatment of erectile dysfunctionCirculation20041103149315515533876
   PubMed Web of Science ®Google Scholar
• Straight HealthcareCytochrome 450 3A Available from: http://www.straighthealthcare.com/cytochrome-p450-3a4.html#howAccessed April 27, 2015
   Google Scholar
• NehraAKulaksizogluHGlobal perspectives and controversies in the epidemiology of male erectile dysfunctionCurr Opin Urol200212649349612409879
   PubMedGoogle Scholar
• GandagliaGBrigantiAJacksonGA systematic review of the association between erectile dysfunction and cardiovascular diseaseEur Urol201465596897824011423
   PubMed Web of Science ®Google Scholar
• ViragRBouillyPFrydmanDIs impotence an arterial disorder? A study of arterial risk factors in 440 impotent menLancet1985184221811842857264
   PubMed Web of Science ®Google Scholar
• JavaroniVNevesMFErectile dysfunction and hypertension: impact on cardiovascular risk and treatmentInt J Hypertens2012201262727822649713
   PubMedGoogle Scholar
• NunesKPLabaziHWebbRCNew insights into hypertension-associated erectile dysfunctionCurr Opin Nephrol Hypertens201221216317022240443
   PubMed Web of Science ®Google Scholar
• SeftelADSunPSwindleRThe prevalence of hypertension, hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunctionJ Urol20041716 Pt 12341234515126817
   PubMed Web of Science ®Google Scholar
• Zaman HuriHLian ChooTSulaimanCZMarkRAbdul RazackAHOral drug treatments in patients with erectile dysfunction and multiple comorbidities: a retrospective observational studyBMJ Open201447e005381
   PubMed Web of Science ®Google Scholar
• KirbyMCreangaDLStecherVJErectile function, erection hardness and tolerability in men treated with sildenafil 100 mg vs. 50 mg for erectile dysfunctionInt J Clin Pract201367101034103924073975
   PubMed Web of Science ®Google Scholar
• NobiliAGarattiniSMannucciPMMultiple diseases and polyphar-macy in the elderly: challenges for the internist of the third millenniumJOC2011112844
   Google Scholar
• SlabaughSLMaioVTemplinMAbouzaidSPrevalence and risk of polypharmacy among the elderly in an outpatient setting: a retrospective cohort study in the Emilia-Romagna region, ItalyDrugs Aging201027121019102821087071
   PubMed Web of Science ®Google Scholar
• Zaman HuriHFun WeeHDrug related problems in type 2 diabetes patients with hypertension: a cross-sectional retrospective studyBMC Endocr Disord201313223289895
   PubMed Web of Science ®Google Scholar
• Zaman HuriHChai LingLDrug-related problems in type 2 diabetes mellitus patients with dyslipidemiaBMC Pub Health201313119224341672
   PubMed Web of Science ®Google Scholar
• KimS-CLeeY-SSeoK-KJungG-WKimT-HReasons and predictive factors for discontinuation of PDE-5 inhibitors despite successful intercourse in erectile dysfunction patientsInt J Impot Res2014263879324305610
   PubMed Web of Science ®Google Scholar
• ChangLLMaMAllmenHVHendersonSCHarperKHornbuckleKCo-possession of phosphodiesterase type-5 inhibitors (PDE5-I) with nitratesCurr Med Res Opin20102661451145920394470
   PubMed Web of Science ®Google Scholar
• SchwartzBGKlonerRADrug interactions with phosphodiesterase-5 inhibitors used for the treatment of erectile dysfunction or pulmonary hypertensionCirculation20101221889520606131
   PubMed Web of Science ®Google Scholar
• Viagra^® (sildenafil) [prescribing information]Pfizer2010
   Google Scholar
• Levitra^® (vardenafil) [prescribing information]Wayne, NJBayer Healthcare/GlaxoSmithKline2011
   Google Scholar
• Cialis^® (tadalafil) [prescribing information]Indianapolis, INEli Lilly2011
   Google Scholar
• SandnerPHutterJTinelHZiegelbauerKBischoffEPDE5 inhibitors beyond erectile dysfunctionInt J Impot Res200719653354317625575
   PubMed Web of Science ®Google Scholar
• CuiHLiuBSongZEfficacy and safety of long-term tadalafil 5 mg once daily combined with sildenafil 50 mg as needed at the early stage of treatment for patients with erectile dysfunctionAndrologia2015471202424387078
   PubMed Web of Science ®Google Scholar
• KlonerRASadovskyRJohnsonEGMoDAhujaSEfficacy of tadalafil in the treatment of erectile dysfunction in hypertensive men on concomitant thiazide diuretic therapyInt J Impot Res200517545045416015377
   PubMed Web of Science ®Google Scholar
• StröbergPKaminetskyJCParkNCGoldfischerERCreangaDLStecherVJHardness, function, emotional well-being, satisfaction and the overall sexual experience in men using 100-mg fixed-dose or flexible-dose sildenafil citrateInt J Impot Res201022428428920596083
   PubMed Web of Science ®Google Scholar
• KirbyMChappleCJacksonGErectile dysfunction and lower urinary tract symptoms: a consensus on the importance of co-diagnosisInt J Clin Pract201367760661823617950
   PubMed Web of Science ®Google Scholar
• McMahonCGHigh dose sildenafil citrate as a salvage therapy for severe erectile dysfunctionInt J Impot Res200214653353812494291
   PubMed Web of Science ®Google Scholar
• StarkSSachseRLiedlTVardenafil increases penile rigidity and tumescence in men with erectile dysfunction after a single oral doseEur Urol2001402181188 discussion 181–19011528196
   PubMed Web of Science ®Google Scholar
• CroweSMStreetmanDSVardenafil treatment for erectile dysfunctionAnn Pharmacother2004381778514742800
   PubMed Web of Science ®Google Scholar
• ParkNCKimTNParkHJTreatment strategy for non-responders to PDE5 inhibitorsWorld J Mens Health2013311313523658863
   PubMedGoogle Scholar
• ScrantonREGoldsteinIStecherVJErectile dysfunction diagnosis and treatment as a means to improve medication adherence and optimize comorbidity managementJ Sex Med201310255156123153075
   PubMed Web of Science ®Google Scholar
• CarvalheiraAForjazVPereiraNMAdherence to phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction in long-term users: how do men use the inhibitors?Sex Med2014229610225356304
   PubMed Web of Science ®Google Scholar
• YanHZongHCuiYLiNZhangYThe efficacy of PDE5 inhibitors alone or in combination with alpha-blockers for the treatment of erectile dysfunction and lower urinary tract symptoms due to benign prostatic hyperplasia: a systematic review and meta-analysisJ Sex Med20141161539154524621088
   PubMed Web of Science ®Google Scholar
• HowesLDiltiazem-mediated inhibition of sildenafil metabolism may promote nitrate-induced hypotensionInt Med J2001316373 author reply 374–375
   Google Scholar
• HuangSTJiannBPAssessing satisfaction in men and their female partners after treatment with phosphodiesterase type 5 inhibitors for erectile dysfunctionInt J Impot Res201325517818223466660
   PubMed Web of Science ®Google Scholar
• KlonerRErectile dysfunction and hypertensionInt J Impot Res200719329630217151696
   PubMed Web of Science ®Google Scholar
• BrackettNLLynneCMIbrahimEOhlDASonksenJTreatment of infertility in men with spinal cord injuryNat Rev Urol20107316217220157304
   PubMed Web of Science ®Google Scholar
• ValeJBenign prostatic hyperplasia and erectile dysfunction – is there a link?Curr Med Res Opin200016Suppl 1s63s6711329825
   PubMed Web of Science ®Google Scholar
• RosenRCGiulianoFCarsonCCSexual dysfunction and lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH)Eur Urol200547682483715925080
   PubMed Web of Science ®Google Scholar
• GovorovAKasyanGPriymakDPushkarDSorsaburuSTadalafil in the management of lower urinary tract symptoms: a review of the literature and current practices in RussiaCent Eur J Urol2014672167177
   PubMedGoogle Scholar
• StegemannSEckerFMaioMGeriatric drug therapy: neglecting the inevitable majorityAgeing Res Rev20109438439820478411
   PubMed Web of Science ®Google Scholar
• StemerGLemmens-GruberRClinical pharmacy activities in chronic kidney disease and end-stage renal disease patients: a systematic literature reviewBMC Nephrol2011123521777480
   PubMed Web of Science ®Google Scholar
• RamaMViswanathanGAcharyaLDAtturRPReddyPNRaghavanSVAssessment of drug-drug interactions among renal failure patients of nephrology ward in a south Indian tertiary care hospitalIndian J Pharm Sci2012741636823204624
   PubMed Web of Science ®Google Scholar
• AyubWFletcherSEnd-stage renal disease and erectile dysfunction. Is there any hope?Nephrol Dial Transplant200015101525152811007818
   PubMed Web of Science ®Google Scholar
• LasaponaraFSedighOPasqualeGPhosphodiesterase type 5 inhibitor treatment for erectile dysfunction in patients with end-stage renal disease receiving dialysis or after renal transplantationJ Sex Med201310112798281423346948
   PubMed Web of Science ®Google Scholar
• PietteJDKerrEAThe impact of comorbid chronic conditions on diabetes careDiabetes Care200629372573116505540
   PubMed Web of Science ®Google Scholar
• RosenRCJacksonGKostisJBErectile dysfunction and cardiac disease: recommendations of the Second Princeton ConferenceCurr Urol Rep20067649049617052447
   PubMedGoogle Scholar
• McLaughlinTHarnettJBurhaniSScottBEvaluation of erectile dysfunction therapy in patients previously nonadherent to long-term medications: a retrospective analysis of prescription claimsAm J Ther200512660561116280655
   PubMedGoogle Scholar
• ViigimaaMVlachopoulosCLazaridisADoumasMManagement of erectile dysfunction in hypertension: tips and tricksWorld J Cardiol20146990891525276292
   PubMedGoogle Scholar
• GolchinNFrankSHVinceAIshamLMeropolSBPolypharmacy in the elderlyJ Res Pharm Pract201542858825984546
   PubMedGoogle Scholar